Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
CRISPR Therapeutics AG - Common Shares
(NQ:
CRSP
)
55.97
-0.28 (-0.50%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 16, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,144,670
Open
55.68
Bid (Size)
55.50 (100)
Ask (Size)
56.60 (1,000)
Prev. Close
56.25
Today's Range
55.29 - 57.58
52wk Range
30.04 - 78.48
Shares Outstanding
78,935,098
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes
Today 12:00 EST
Issued on behalf of Avant Technologies Inc.
From
USA News Group
Via
GlobeNewswire
2 Monster Stocks in the Making to Buy and Hold
↗
Today 10:50 EST
The next 12 months will tell us more about their prospects.
Via
The Motley Fool
Performance
YTD
+35.1%
+35.1%
1 Month
+1.2%
+1.2%
3 Month
-8.5%
-8.5%
6 Month
+29.6%
+29.6%
1 Year
+26.5%
+26.5%
More News
Read More
12 Days of Investing: My Top 12 Stocks to Buy Before 2026
↗
December 15, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Retail Bulls Call CRISPR ‘Criminally Undervalued’ After Gene-Editing Breakthrough Cuts Cholesterol By 70%
↗
November 10, 2025
Via
Stocktwits
2 Healthcare Stocks to Buy Ahead of the New Year
↗
December 12, 2025
Via
The Motley Fool
2 Stocks That Could Soar by 52% and 282%, According to Wall Street
↗
December 07, 2025
Via
The Motley Fool
Meet the Beaten-Down Biotech Stock Cathie Wood Loves That Wall Street Says May Soar 50%
↗
November 30, 2025
Via
The Motley Fool
Topics
ETFs
The Best Stocks to Buy With $1,000 Right Now
↗
November 29, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Energy
3 Mid-Cap Growth Stocks That Have Mammoth Long-Term Potential
↗
November 21, 2025
Via
The Motley Fool
Agios Pharmaceuticals Plunges Over 50% as Sickle Cell Drug Delivers Mixed Phase 3 Results
November 19, 2025
Via
MarketMinute
Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.
↗
November 19, 2025
Via
The Motley Fool
1 Underrated Stock That Could Soar by 58%, According to Wall Street
↗
November 17, 2025
Via
The Motley Fool
The Tech Tsunami: How Breakthroughs in AI, Quantum, and Green Energy Are Reshaping the Stock Market
November 14, 2025
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Economy
ARK Sold Almost 400,000 Shares of CRISPR Therapeutics. Is Cathie Wood Worried?
↗
November 12, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
CRISPR Therapeutics' Investigational Gene Therapy Shows Promising Lipid-Lowering Effects In Early Trial
↗
November 11, 2025
Via
Benzinga
Why Gene-Editing Giants Crispr And Intellia Just Surged
↗
November 10, 2025
Via
Investor's Business Daily
Topics
Death
Intellia Therapeutics Crashes After A Patient In Its Pivotal Study Dies
↗
November 07, 2025
Via
Investor's Business Daily
Topics
Death
AI Unlocks Gene-Editing Revolution: $2 Million Grant Propels Disease Cures
November 06, 2025
Via
TokenRing AI
Topics
Artificial Intelligence
Climate Change
Intellectual Property
Cathie Wood Goes All-In On Peter Thiel's Crypto Play Bullish With Back-To-Back Million-Dollar Buys
↗
November 04, 2025
Via
Benzinga
AI Unleashes a New Era in Cell and Gene Therapy: A Quarter Century Update Reveals Transformative Potential
November 04, 2025
Via
TokenRing AI
Topics
Artificial Intelligence
Prediction: 2 Stocks That Will Be Worth More Than SoundHound AI 2 Years From Now
↗
November 04, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Intellia Freezes Key Trial After Serious Liver Event, Stock Tumbles
↗
October 27, 2025
Via
Benzinga
2 Soaring Cathie Wood Stocks to Buy and Hold
↗
October 17, 2025
Via
The Motley Fool
New to Growth Stocks? Here's 1 Every Investor Should Have on Their Radar.
↗
October 16, 2025
Via
The Motley Fool
3 Monster Stocks to Hold for the Next 10 Years
↗
October 15, 2025
Via
The Motley Fool
Frequently Asked Questions
Is CRISPR Therapeutics AG - Common Shares publicly traded?
Yes, CRISPR Therapeutics AG - Common Shares is publicly traded.
What exchange does CRISPR Therapeutics AG - Common Shares trade on?
CRISPR Therapeutics AG - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for CRISPR Therapeutics AG - Common Shares?
The ticker symbol for CRISPR Therapeutics AG - Common Shares is CRSP on the Nasdaq Stock Market
What is the current price of CRISPR Therapeutics AG - Common Shares?
The current price of CRISPR Therapeutics AG - Common Shares is 55.97
When was CRISPR Therapeutics AG - Common Shares last traded?
The last trade of CRISPR Therapeutics AG - Common Shares was at 12/16/25 04:00 PM ET
What is the market capitalization of CRISPR Therapeutics AG - Common Shares?
The market capitalization of CRISPR Therapeutics AG - Common Shares is 4.42B
How many shares of CRISPR Therapeutics AG - Common Shares are outstanding?
CRISPR Therapeutics AG - Common Shares has 4B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.